Modified polynucleotides for the production of oncology-related proteins and peptides
US10501513B2 · kind B2 · utility
10Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2017 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Feb 6, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions including polynucleotides encoding polypeptides which have been chemically modified by replacing the uridines with 1-methyl-pseudouridine to improve one or more of the stability and/or clearance in tissues, receptor uptake and/or kinetics, cellular access by the compositions, engagement with translational machinery, mRNA half-life, translation efficiency, immune evasion, protein production capacity, secretion efficiency, accessibility to circulation, protein half-life and/or modulation of a cell's status, function, and/or activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.